ClinicalTrials.gov
ClinicalTrials.gov Menu

Effective Endurance Training in Metabolic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00218998
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : March 31, 2017
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:
To see how fast and how much physical training can reduce risk factors related to metabolic syndrome

Condition or disease Intervention/treatment Phase
Impaired Glucose Tolerance Overweight Hypertension Dyslipidemia Behavioral: exercise training Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Prevention
Official Title: Effective Endurance Training in Metabolic Syndrome
Actual Study Start Date : January 2004

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. To reduce risk factors related to metabolic syndrome

Secondary Outcome Measures :
  1. Improve endothelial functions in patient with metabolic syndrome


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • insulin resistance, impaired glucose tolerance or type 2-diabetes, including two or more of the following factors: Blood pressure ≥ 140/90 mm Hg, Triglycerides Fasting ≥ 1,7 mmol/l, and/or low HDL-cholesterol (≤ 0,9 mmol/l in men, ≤ 1,0 mmol/l in women)
  • Obesity, Waist-hip ratio ≥ 0,9 in men, ≥ 0,85 in women or BMI (body mass index) ≥ 30 kg/m2
  • Microalbuminuria (albumin secretion ≥ 20 mg/l or 20 - 200 g per minute)

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00218998


Locations
Norway
The medical faculty at norwegian university of science and technology
Trondheim, Norway, 7489
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Study Chair: Ulrik E Wisløff, Phd prof NTNU

Publications of Results:
Other Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00218998     History of Changes
Other Study ID Numbers: Training in metabolic syndrome
First Posted: September 22, 2005    Key Record Dates
Last Update Posted: March 31, 2017
Last Verified: March 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Norwegian University of Science and Technology:
Exercise
Exercise therapy

Additional relevant MeSH terms:
Overweight
Metabolic Syndrome X
Dyslipidemias
Glucose Intolerance
Body Weight
Signs and Symptoms
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases
Lipid Metabolism Disorders
Hyperglycemia